Oncoinvent develops new radiopharmaceutical products for better treatment options for cancer patients.
Oncoinvent has raised $11.8M in total funding. The most recent round was Undisclosed. The last funding was announced in December 2024.
Oncoinvent's investors include Hadean Ventures, Canica, MP Pensjon, Watrium AS, Geveran Trading.
Oncoinvent is headquartered in Oslo, Norway.
Oncoinvent develops new radiopharmaceutical products for better treatment options for cancer patients.
Oncoinvent is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oncoinvent — Funding & Investors." VCBacked, December 4, 2024, https://www.vcbacked.co/company/oncoinvent. Accessed September 30, 2026.
VCBacked. (2024). Oncoinvent — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/oncoinvent
{{cite web |title=Oncoinvent — Funding & Investors |url=https://www.vcbacked.co/company/oncoinvent |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated